Algorithm for diagnosing pulmonary fibrosis in tropical countries

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 5, 1998, Pages 294-299

  Jindal, Surinder K ^a   Gupta, Dheeraj ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANAMNESIS; BIOPSY; BRONCHIECTASIS; BRONCHITIS; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE PROCESSING; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TUBERCULOSIS; METHODOLOGY; PHYSICAL EXAMINATION; RADIOGRAPHY; REVIEW; THORACOSCOPY; TROPIC CLIMATE;

ALGORITHMS; BIOPSY; BRONCHIECTASIS; BRONCHITIS; CHRONIC DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; THORACOSCOPY; TOMOGRAPHY, X-RAY COMPUTED; TROPICAL CLIMATE; TUBERCULOSIS, PULMONARY;

EID: 0032148995     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199809000-00009     Document Type: Article

References (44)

1. Jindal SK, Gupta D: Incidence and recognition of interstitial pulmonary fibrosis in developing countries. Curr Opin Pulm Med 1997, 3:378-383. A comprehensive review of different causes of pulmonary fibrosis reported from India. IPF accounts for about half of the cases. CTDs, sarcoidosis, and pneumoconioses are some of the other important causes.
2. Jindal SK, Malik SK, Deodhar SD, Sharma BK: Fibrosing alveolitis: a report of 61 cases seen over the past five years. Indian J Chest Dis Allied Sci 1979, 21:174-179.
3. Crystal RG, Bitterman PB, Rennard SI, Hanset AJ, Keogh BA: Interstitial lung diseases of unknown causes: disease characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984, 310:154-166.
4. Mortenson RL, Bogin RM, King TE Jr: Interstitial lung diseases. In Recent Advances in Respiratory Medicine, No. 5. Edited by Mitchell DM. Edinburgh: Churchill Livingstone; 1991:163-184.
5. duBois RM: Diffuse lung disease: a view for the future. Sarcoidosis Vasculitis Diffuse Lung Dis 1997, 14:23-30. Reviews the importance of diffuse lung diseases and the role of investigations such as BAL, CT, and lung biopsy in making a diagnosis.
6. Turner-Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980, 35:171-180.
7. Schwarz MI: Radiological recognition of chronic diffuse lung disease. In Interstitial Lung Disease. Edited by Schwarz MI, King TE Jr. Philadelphia: Dekker; 1988:27-36.
8. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 1976, 85:769-788.
9. Gupta D, Kumar S, Jindal SK: Bilateral miliary mottling without hilar lymphadenopathy: a rare presentation of sarcoidosis. Lung India 1996, 14:87-88.
10. Cherniack RM: Physiological disturbances in interstitial lung disease. In Interstitial Lung Disease. Edited by Schwarz MI, King TE Jr. Philadelphia: Decker; 1988:37-44.
11. Renzoni E, Rottoli P, Coviello G, Perari MG, Galeazzi M, Vagliasindi M: Clinical laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease. Clin Rheumatol 1997, 16:570-577.
12. Erbes R, Schaberg T, Loddenkemper R: Lung function tests in patients • with idiopathic pulmonary fibrosis: are they helpful for predicting outcome? Chest 1997, 111:51-57. The study demonstrates the usefulness of standard tests to assess the prognosis of patients with IPF. The results are of particular importance in the developing countries.
13. Kirtland SH, Winterbaner RH: Pulmonary function tests and idiopathic pulmonary fibrosis: simple may be better. Chest 1997, 111:7-8.
14. Chan-Yeung M, Muller NL: Cryptogenic fibrosing alveolitis. Lancet 1997, 350:651-656. A brief seminar focused on diagnosis and other aspects of this disease. The authors provide a lucid and simplified description of the differential diagnosis and the indications for open lung biopsy.
15. Wells AU, Rubens MB, duBois RM, Hansell DM: Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am J Radiol 1993, 161:1159-1165.
16. Grenier P, Chevret S, Beigelman C Brauner MW, Chastang C, Valeyre D: Chronic diffuse infiltrative disease: determination of the diagnostic value of clinical data, chest radiography and CT and Bayesian analysis. Radiology 1994, 191:383-390.
17. 7. Tung KT, Wells AU, Rubens MB, Kirk JME, duBois RM, Hansell DM: Accuracy of typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993, 48:334-338.
18. Primack SL, Hartman TE, Hansell DM, Muller NL: End stage lung disease: CT findings in 61 patients. Radiology 1993, 189:681-686.
19. Kaltreider HB: Interstitial lung disease: selected aspects. Pulm Perspect 1993, 10:6-8.
20. Holt RM, Schmidt RA, Godwin JD, Raghu G: High resolution CT in assisted tomography in respiratory bronchiolitis associated interstitial lung disease. J Comput Assist Tomog 1993, 17:46-50.
21. Johkoh T, Ikezoe J, Kohno N, Takeuchi N, Yamagami H, Tomiyama N, et al.: High resolution CT and pulmonary function tests in collagen vascular disease: comparison with ideopathic pulmonary fibrosis. Eur J Radiol 1994, 18:113-121.
22. McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C: High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994, 33:118-122.
23. Lim MK, Im JG, Ahn JM, Kim JH, Lee SK, Yeon KM, Han MC: Idiopathic pulmonary fibrosis versus pulmonary involvement of collagen vascular disease: HRCT findings. J Korean Med Sci 1997, 12:492-498.
24. Raghu G: Interstitial lung disease: a diagnostic approach. Am J Respir Crit Care Med 1995, 151:909-914.
25. Niimi H, Kang EY, Kwong JS, Carignan S, Muller NH: CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy. J Comput Assist Tomogr 1996, 20:305-308.
26. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S: CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997, 168:79-83.
27. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al.: Thin section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997, 169:977-983.
28. Baughman RP: Use of bronchoscopy in the diagnosis of infection in the immuno compromised host. Thorax 1994, 49:3-7.
29. Goldstein RA, Rohatgi PK, Bergofsky EH, Block ER: Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990, 142:481-486.
30. Hance AJ: Pulmonary immune cells in health and disease: dendritic cells and Langerhans' cells. Eur Respir J 1993, 6:1213-1220.
31. King TE Jr, Mortenson RL: Bronchoalveolar lavage in patients with connective tissue disease. J Thorac Imaging 1992, 7:26-48.
32. BAL Cooperative Group Steering Committee: Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. Am Rev Respir Dis 1990. 141(suppl):S169-S202.
33. Capelli A, Lusuardi A, Cerutti CG, Donner CF: Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders. Am J Respir Crit Care Med 1997, 155:249-253.
34. Behera D, D'Souza GA, Rajwanshi A, Jindal SK: Bronchoalveolar lavage: cellular characteristics in patients with idiopathic pulmonary fibrosis and sarcoidosis. Indian J Chest Dis Allied Sci 1990, 32:107-110.
35. Gupta D, Jorapur V, Bambery P, Joshi K, Jindal SK: Pulmonary sarcoidosis: spirometric correlation with transbronchial biopsy. Sarcoidosis Vasculitis Diffuse Lung Dis 1997, 14:77-80. There was a rough correlation between forced vital capacity and the histologic granuloma load, interstitial inflammation, and the overall histopathological score on transbronchial lung biopsy in 28 patients with pulmonary sarcoidosis.
36. Gupta D, Behera D, Joshi K, Jindal SK: Role of fiberoptic bronchoscopy (transbronchial lung biopsy) in diagnosis of parenchymatosus lung disease. J Assoc Physicians India 1997, 45:371-373. Results of transbronchial lung biopsies in patients with diffuse interstitial lung disease in India.
37. Shah SS, Tsang V, Goldstraw P: Open lung biopsy: a safe, reliable and accurate method for diagnosis in diffuse lung disease. Respiration 1992, 59:243-246.
38. Venn GE, Kay PH, Midwood CJ, Goldstraw PJ: Open biopsy in patients with diffuse pulmonary shadowing. Thorax 1985, 40:931-935.
39. Bensaid DD, McIntyre RC Jr, Waring BJ, Simon JS: Comparison of videothoracic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 1993, 103:765-770.
40. Carnocham FM, Walker WS, Cameron EWJ: Efficacy of video assisted thoracoscopic lung biopsy: an historical comparison with open lung biopsy. Thorax 1994, 49:361-363.
41. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157:199-203. The median survival of patients with IPF differed depending upon the histological subsets. Patients with usual interstitial pneumonia had the worst prognosis.
42. Kasuga I, Yonemaru M, Kiyokawa H, Ichinos Y, Toyama K: Clinical evaluation of serum type IV collagen 7 S in idiopathic pulmonary fibrosis. Respirology 1996, 1:277-281.
43. Banghman RP, Fernandez M: Radionuclide imaging in interstitial lung disease. Curr Opin PuIm Med 1996, 2:376-379.
44. Jin S, Wang G, He B, Zhu M: Gallium-67 scanning for detection of alveolitis in idiopathic pulmonary fibrosis and sarcoidosis. Chin Med J 1996, 109:579-521.